Hocoma Named One of the Swiss Champions
PwC assessed small and mid-sized companies with head offices in Switzerland that are considered to be market leaders on at least one continent, or the best in their specific industry.
They found that three factors were common among these companies: client orientation, a culture of innovation and strong research and development.
At Hocoma, all three factors are present in the day-to-day. Hocoma was founded on a basis of research and development; and innovation still drives the solutions that help patients get back to their normal daily life and therapists to help their patients achieve that.
When asked how the company dealt with competition in the market, Dr. Gery Colombo, CEO of Hocoma, pointed out that similar products exist or are being introduced into the market, mainly in China. Hocoma, however, covers the entire value chain from research to customer training, a comprehensive concept other companies simply can’t match.
Swiss world market leaders are niche suppliers with high production costs. They are only able to survive in the global market if their products are of the absolute best quality and if they are focused on the needs of their customers.
Dr. Colombo continued by saying, "Hocoma employees know what they’re working toward. They understand they have the power to revolutionize an industry and change people’s lives for the better. And that is all the motivation I need."
"Swiss Champions: Agile, innovative and resistant to crisis" http://www.pwc.ch/... w.pwc.ch%2Fde%2Fpublikationen.html
All Hocoma products are medical devices and must be used in strict adherence to the User Manual; failure to do so may result in serious personal injury. It is strongly recommended that you regularly consult Hocoma’s website (www.hocoma.com/legalnotes) for the latest available information. Please contact Hocoma in case of any questions.
Use only under the supervision of qualified medical personnel. However, certain Hocoma products are marketed for home use and must be strictly used according to the recommendations of your medical care provider who is knowledgeable about your specific needs. Consult the User Manual and Hocoma’s website (www.hocoma.com/legalnotes) for appropriate product designation. Failure to obtain and follow the recommendations of your medical care provider may result in serious personal injury.
This information provides details about medical products which may not be available in all countries and may not have received approval or market clearance by all governmental regulatory bodies throughout the world. Nothing herein should be construed as a solicitation or promotion of any product or of an indication of any specific use for any product which is not authorized by the laws and regulations of the country where the reader of this information resides.
A successful therapy begins in patients' heads. In the firm belief that - step by step - they can reach their goals and regain quality of life.
This is what we work for at the Swiss medtech company Hocoma. With technologies and ideas that look at functional movement therapy from a completely different angle. Because they enable independent exercises and create maximum motivation. Because they challenge people to take courage and support their hopes with personal achievements.
We are committed to creating the ideal therapy. Our awarded robotic and sensor-based devices offer solutions for intensive gait therapy (Lokomat®, Andago®), functional therapy of the upper extremities (Armeo®), robotic mobilization and functional electrical stimulation in early Rehabilitation (Erigo®) as well as functional movement therapy within low back pain treatment (Valedo® Therapy Concept) at home and at the clinic. They are the result of intensive research, consistent development and continuous exchange with patients, therapists and partners in research and science.
Those who see to break new grounds need to stay open to exceptional ideas. They have the potential of being exceptionally effective. This guiding principle by Hocoma founder and CEO Dr. Gery Colombo has accompanied us since our start in 2000 and is still lived and implemented by our dedicated employees around the world. At the headquarters in Volketswil near Zurich (Switzerland) and the subsidiaries in the USA, Singapore and Slovenia they achieved a turnover of more than 30 million CHF in 2014.
Press releases you might also be interested in
Weitere Informationen zum Thema "Medizintechnik":
So halten Unternehmen die Compliance mit Cognitive Computing ein
Der folgende Artikel von Stefan Welcker, Managing Director DACH, Expert System Deutschland, erläutert, warum Automatisierung im digitalen Zeitalter nur mit Cognitive Computing und Künstlicher Intelligenz zuverlässig funktionieren kann.Weiterlesen